Xencor Inc SEC filings XNCR
Xencor Inc has 897 filings in SEC EDGAR's recent list, going back to May 6, 2005. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Feb 25, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 25, 2026 | — |
| 424B5 | Prospectus supplement | Sep 12, 2024 | — |
| 424B5 | Prospectus supplement | Sep 10, 2024 | — |
| S-8 | Employee stock plan registration | Jun 16, 2023 | — |
| S-8 POS | Filing | Jun 16, 2023 | — |
| S-8 POS | Filing | Jun 16, 2023 | — |
| S-8 POS | Filing | Jun 16, 2023 | — |
| S-8 POS | Filing | Jun 16, 2023 | — |
| S-3ASR | Automatic shelf registration | Feb 27, 2023 | — |
| S-8 | Employee stock plan registration | Aug 3, 2022 | — |
| S-8 | Employee stock plan registration | Feb 25, 2020 | — |
| 424B5 | Prospectus supplement | Mar 21, 2018 | — |
| 424B5 | Prospectus supplement | Mar 19, 2018 | — |
| S-3ASR | Automatic shelf registration | Mar 19, 2018 | — |
| S-8 | Employee stock plan registration | Mar 1, 2017 | — |
| 424B5 | Prospectus supplement | Dec 1, 2016 | — |
| 424B5 | Prospectus supplement | Nov 30, 2016 | — |
| 424B5 | Prospectus supplement | Oct 5, 2016 | — |
| S-3 | Shelf registration | Sep 19, 2016 | — |
| 424B5 | Prospectus supplement | Feb 25, 2015 | — |
| 424B5 | Prospectus supplement | Feb 23, 2015 | — |
| 424B3 | Prospectus | Jan 23, 2015 | — |
| S-3 | Shelf registration | Jan 7, 2015 | — |
| S-8 | Employee stock plan registration | Dec 3, 2013 | — |
| 424B4 | Prospectus | Dec 3, 2013 | — |
| S-1/A | Amended registration statement | Dec 2, 2013 | — |
| S-1/A | Amended registration statement | Nov 14, 2013 | — |
| S-1/A | Amended registration statement | Nov 4, 2013 | — |
| S-1/A | Amended registration statement | Oct 25, 2013 | — |
| S-1 | Registration statement | Oct 11, 2013 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XNCR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Pasadena, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1326732
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.